[Transcranial magnetic stimulation in neurotic depression]

Area of Science:

• Neuroscience
• Psychiatry
• Clinical Psychology

Background:

• Neurotic depression is a significant mental health concern.
• Psychotherapy is a common treatment for depression.
• Investigating novel therapeutic approaches for depression is crucial.

Purpose of the Study:

• To evaluate the efficacy of combining Transcranial Magnetic Stimulation (TMS) with psychotherapy for neurotic depression.
• To compare the outcomes of combined TMS and psychotherapy against a sham TMS control group.

Main Methods:

• A randomized controlled trial was conducted with 15 patients in the experimental group and 14 in the control group.
• The experimental group received daily TMS (0.015 T, 40 Hz) for 20 minutes, applied to the left prefrontal area, concurrently with psychotherapy.
• The control group received a sham TMS procedure.
• Depression and anxiety levels were assessed using the Hamilton Depression Rating Scale and the Anxiety Inventory.

Main Results:

• 13 out of 15 patients in the experimental group showed mental state improvement, compared to 3 out of 14 in the control group.
• TMS combined with psychotherapy led to a significant reduction in depression scores (Hamilton scale: 22.9 to 8.6) and anxiety scores (Anxiety Inventory: 39.4 to 26.6).
• No significant changes in blood pressure, pulse rate, or pathological electroencephalogram (EEG) symptoms were observed in relation to TMS.

Conclusions:

• Combined TMS and psychotherapy is an effective treatment for neurotic depression, yielding significantly better outcomes than sham TMS.
• The treatment demonstrates a favorable safety profile with no adverse effects on vital signs or EEG.
• Further research into TMS as an adjunctive therapy for depressive disorders is warranted.